CN104547150A

CN104547150A - Application of inflammation-diminishing and pain-relieving external medicine as oral agent for treating tumors and ulcerative carbuncles

Info

Publication number: CN104547150A
Application number: CN201410820506.7A
Authority: CN
Inventors: 夏永利
Original assignee: Individual
Current assignee: Individual
Priority date: 2014-12-17
Filing date: 2014-12-17
Publication date: 2015-04-29

Abstract

The invention discloses an application of an inflammation-diminishing and pain-relieving external medicine as an oral agent. The method comprises the following specific steps: taking 10-80 parts of hedyotis diffusa, 5-10 parts of scorpion, 5-10 parts of spiders, 10-30 parts of toads and 15-35 parts of centipede which are naturally dried, processing the materials into powder respectively, mixing evenly, and packaging 10 g of the powder in each bag. For patients with tumors and ulcerative carbuncles, which grow in digestive tracts, livers, gallbladders, spleens and pancreatic organs, a small dose of the external medicine is taken in the beginning, the external medicine is orally taken twice a day, and a bag of the external medicine is taken each time. The number of bags can be gradually increased to be three according to the dose required for treatment and the physical situation. The oral medicine can be independently used and also can be cooperatively used with other external medicines. The medicine has the advantages that a brand-new method for applying an external medicine component to oral treatment is provided, and the medicine is applied to the tumors and the ulcerative carbuncles, which grow in the digestive tracts, the livers, the gallbladders, the spleens and the pancreatic organs.

Description

Inflammation-resisting pain-stopping external use medicine is as the application of tumor, carbuncle skin ulcer treatment oral agents

Technical field

The present invention relates to the application of a kind of inflammation-resisting pain-stopping external use medicine as tumor, carbuncle skin ulcer treatment oral agents, its scope of application is growth in the tumor of digestive tract and liver, gallbladder, lung, spleen, pancreas device or carbuncle skin ulcer.

Technical background

Within 2009 to 2012, the applicant successively have submitted " external application Chinese medicine 200910071415.7 of a kind of relaxing muscles and tendons to promote blood circulation, anti-inflammatory analgetic ", " a kind of external application Chinese medicine 201210238056.1 of anti-inflammatory analgetic " and " a kind of external application Chinese medicine 201210238058.0 for the treatment of tumor " more than one piece application for a patent for invention, and the common ground of this several drugs is all concentrate to employ the larger Chinese medicinal components of multiple toxicity.In clinical practice for many years, these external used medicines achieve well-content therapeutic effect, for many patients relieve slight illness, and create many incredible miracles.The most outstanding feature of these medicines is that curative effect is rapid especially, is all that several subsides just take effect usually, and is that subsides are than a subsides successful.Our emphasis is used it for the treatment of oncosis and is achieved very significant curative effect in recent years.But we also find over the course for the treatment of, due to the restriction by administering mode, these medicine for external use are far apart from body surface for some, and the focus curative effect of hiding in internal organs depths is comparatively slow, usually can only seek hasty breaching by increasing drug dose.

Summary of the invention,

The technical problem to be solved in the present invention is to provide the application process of a kind of anti-inflammatory analgetic class medicine for external use component as oral agents, adopts the method can significantly improve the absorbance of medicine, thus its treatment speed is obviously accelerated.

Application process of the present invention is: the Herba Hedyotidis Diffusae 10-80 part of getting natural drying, Scorpio 5-10 part, Aranea 5-10 part, Bufo siccus 10--30 part, and Scolopendra 15-35 part, is processed into powder respectively, often to wrap 10 grams of packagings after mixing.Plumbum preparatium 100-200 part can also be added in above-mentioned raw materials.

For growth digestive tract and liver, gallbladder, spleen, the tumor of pancreas device, carbuncle skin ulcer patient, when taking from low dose, oral one day twice, each bag.Need dosage and body constitution situation can increase to three guarantees gradually according to treatment.This oral medicine can be used alone, and medicine for external use also can be coordinated to use.

The advantage of medicine of the present invention there is provided a kind of medicine for external use component for the completely new approach of oral medication, the method is that we connected for many years in the past and dare not desire.First this method is be applied to domestic animal experiment, start to carry out clinical having a try to human body on this basis to test, because the method can arrive the focus far apart from body surface fast, thus increase the absorbance of medicine, accelerate treatment process, and treatment in and have no significant toxic and side effects.The inventive method scope of application is that growth is in digestive tract and liver, gallbladder, spleen, the tumor of pancreas device, carbuncle skin ulcer.

Detailed description of the invention

Example 1

Get 100 parts, the Plumbum preparatium of natural drying, Herba Hedyotidis Diffusae 80 parts, Scorpio 10 parts, Aranea 8 parts, Bufo siccus 20 parts, Scolopendra 30 parts, is processed into powder respectively, often to wrap 10 grams of packagings after mixing, for growth digestive tract and liver, gallbladder, spleen, the tumor of pancreas device, carbuncle skin ulcer patient, when taking from low dose, oral one day twice, each bag.When increasing not obvious to curative effect, dosage is increased to 2 bags.201210238058.0 " a kind of external application Chinese medicine for the treatment of tumor " described external used medicine is used while taking this oral medicine.

Example 2

It is below the typical case history of the present invention and " a kind of external application Chinese medicine 201210238058.0 for the treatment of tumor " curative effect comparision.

Lee XX, man, 56 years old, colon cancer is transferred to hepatocarcinoma, Operation of Colon Carcinoma excises, and because perfused rat liver model is too many, cannot perform the operation, cardinal symptom is hepatalgia, paste 201210238058.0 externally applied ointments after three days pain obviously alleviate, paste with after the 10th day, B ultrasonic discovery tuberosity starts to see little, continuing subsides curative effect increases slowly, after use oral medicine of the present invention instead, the mode of external application 201210238058.0 medicine for external use is treated, and effect continues to manifest, after so spending 15 days again, not only pain disappears completely, and B ultrasonic finds that focal nodules reduces further.

King X, female, at the age 87, cancer of pancreas, cannot perform the operation because having a delicate constitution, and adopts half-measure, complete in oral Chinese medicine treatment, DeGrain.Cachectic symptoms is obvious.Paste 201210238058.0 externally applied ointments after 10 days cachectic symptoms obviously alleviate, continue to paste with 5 days, effect increase is not remarkable, after use oral medicine of the present invention instead, the mode of external application 201210238058.0 medicine for external use is treated, after 15 days, cachectic symptoms disappears substantially, and B ultrasonic finds that focus obviously reduces.

In addition, shown by more than 20 name tumor patient treatments, when bringing into use various externally applied ointment simultaneously, various embodiments of the present invention medicine for oral administration can shorten one times nearly than using merely externally applied ointment to obtain identical curative effect required time.

Claims

1. anti-inflammatory analgetic class medicine for external use component is as an application process for oral agents, it is characterized in that: the Herba Hedyotidis Diffusae 10-80 part of getting natural drying, Scorpio 5-10 part, Aranea 5-10 part, Bufo siccus 10--30 part, Scolopendra 15-35 part, be processed into powder respectively, often to wrap 10 grams of packagings after mixing; For growth digestive tract and liver, gallbladder, spleen, the tumor of pancreas device, carbuncle skin ulcer patient, when taking from low dose, oral one day twice, each bag; Can increase to three guarantees gradually according to treatment needs and body constitution situation, this oral medicine is used alone, and medicine for external use also can be coordinated to use.

2. anti-inflammatory analgetic class medicine for external use component, as the application process of oral agents, is characterized in that according to claim 1: in the medicine material that the method uses, add Plumbum preparatium 100-200 part.